Cochrane Abstracts
Rifabutin for treating pulmonary tuberculosis Unchanged
Rifabutin for treating pulmonary tuberculosis Unchanged is a topic covered in the Cochrane Abstracts.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Rifabutin for Treating Pulmonary Tuberculosis Unchanged." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/433052/all/Rifabutin_for_treating_pulmonary_tuberculosis_Unchanged. Accessed 06 July 2022.
Rifabutin for treating pulmonary tuberculosis Unchanged. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433052/all/Rifabutin_for_treating_pulmonary_tuberculosis_Unchanged. Accessed July 6, 2022.
Rifabutin for treating pulmonary tuberculosis Unchanged. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/433052/all/Rifabutin_for_treating_pulmonary_tuberculosis_Unchanged
Rifabutin for Treating Pulmonary Tuberculosis Unchanged [Internet]. In: Cochrane Abstracts. [cited 2022 July 06]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/433052/all/Rifabutin_for_treating_pulmonary_tuberculosis_Unchanged.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Rifabutin for treating pulmonary tuberculosis Unchanged
ID - 433052
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/433052/all/Rifabutin_for_treating_pulmonary_tuberculosis_Unchanged
DB - Evidence Central
DP - Unbound Medicine
ER -
